| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.02 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.085 | 0.02 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.07 | 0.03 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.073 | 0.03 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.03 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.21 | 0.03 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.067 | 0.03 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | 0.14 | 0.03 |